These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 2895941)

  • 21. Sleep-wakefulness effects after microinjections of hypocretin 1 (orexin A) in cholinoceptive areas of the cat oral pontine tegmentum.
    Moreno-Balandrán E; Garzón M; Bódalo C; Reinoso-Suárez F; de Andrés I
    Eur J Neurosci; 2008 Jul; 28(2):331-41. PubMed ID: 18702704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single administration of metyrapone modifies sleep-wake patterns in the rat.
    Drouet JB; Rousset C; Maury R; Michel V; Buguet A; Cespuglio R; Canini F
    Eur J Pharmacol; 2011 Feb; 652(1-3):60-4. PubMed ID: 21114995
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of the 5-HT₆ receptor antagonists SB-399885 and RO-4368554 and of the 5-HT(2A) receptor antagonist EMD 281014 on sleep and wakefulness in the rat during both phases of the light-dark cycle.
    Monti JM; Jantos H
    Behav Brain Res; 2011 Jan; 216(1):381-8. PubMed ID: 20732355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of centrophenoxine on EEG vigilance in the course of sleep deprivation and on the EEG pattern of all-night sleep.
    Brezinová V; Hort V; Vojtĕchovský M
    Act Nerv Super (Praha); 1970 Jan; 12(1):54-6. PubMed ID: 4392147
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of a-fluoromethylhistidine on sleep and wakefulness in the rat. Short note.
    Monti JM; D'Angelo L; Jantos H; Pazos S
    J Neural Transm; 1988; 72(2):141-5. PubMed ID: 3385425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sleep during acute dopamine D1 agonist SKF 38393 or D1 antagonist SCH 23390 administration in rats.
    Monti JM; Fernández M; Jantos H
    Neuropsychopharmacology; 1990 Jun; 3(3):153-62. PubMed ID: 2141985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depletion of brain serotonin by 5,7-DHT: effects on the 8-OH-DPAT-induced changes of sleep and waking in the rat.
    Monti JM; Jantos H; Silveira R; Reyes-Parada M; Scorza C; Prunell G
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):273-7. PubMed ID: 7532312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of oxcarbazepine on sleep architecture.
    Ayala-Guerrero F; Mexicano G; González V; Hernandez M
    Epilepsy Behav; 2009 Jul; 15(3):287-90. PubMed ID: 19379835
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Counterpointing the functional role of the forebrain and of the brainstem in the control of the sleep-waking system.
    Villablanca JR
    J Sleep Res; 2004 Sep; 13(3):179-208. PubMed ID: 15339255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of acute and chronic treatment with amitryptyline on the sleep-wake activity of rats.
    Obál F; Benedek G; Lelkes Z; Obál F
    Neuropharmacology; 1985 Mar; 24(3):223-9. PubMed ID: 3990921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adenosine analogs and sleep in rats.
    Radulovacki M; Virus RM; Djuricic-Nedelson M; Green RD
    J Pharmacol Exp Ther; 1984 Feb; 228(2):268-74. PubMed ID: 6694111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stereoselective antagonism by the pindolol enantiomers of 8-OH-DPAT-induced changes of sleep and wakefulness.
    Monti JM; Jantos H
    Neuropharmacology; 1994 May; 33(5):705-8. PubMed ID: 7936106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of the enkephalinase inhibitor SCH 34826 on the sleep-waking cycle and EEG activity in the rat.
    Trampus M; Conti A; Marzanatti M; Monopoli A; Ongini E
    Neuropharmacology; 1990 Mar; 29(3):199-205. PubMed ID: 2325830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sleep suppressant action of quipazine: relation to central serotonergic stimulation.
    Fornal C; Radulovacki M
    Pharmacol Biochem Behav; 1981 Dec; 15(6):937-44. PubMed ID: 7323120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of methoxamine and alpha-adrenoceptor antagonists, prazosin and yohimbine, on the sleep-wake cycle of the rat.
    Pellejero T; Monti JM; Baglietto J; Jantos H; Pazos S; Cichevski V; Hawkins M
    Sleep; 1984; 7(4):365-72. PubMed ID: 6515252
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat.
    Cavas M; Navarro JF
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):668-78. PubMed ID: 16457926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sleep changes in fasting rats after chronic glycerol feeding.
    Dewasmes G; Duchamp C; Bothorel B; Candas V
    Physiol Behav; 1991 Sep; 50(3):537-41. PubMed ID: 1801006
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of selective neuronal nitric oxide synthase inhibition on sleep and wakefulness in the rat.
    Cavas M; Navarro JF
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):56-67. PubMed ID: 16023276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The actions of dihydroxyphenylalanine and dihydroxyphenylserine on the sleep-wakefulness cycle of the rat after peripheral decarboxylase inhibition.
    Altier H; Moldes M; Monti JM
    Br J Pharmacol; 1975 May; 54(1):101-6. PubMed ID: 166716
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The D1 dopamine receptor antagonist SCH 23390 enhances REM sleep in the rat.
    Trampus M; Ongini E
    Neuropharmacology; 1990 Oct; 29(10):889-93. PubMed ID: 2147740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.